Journal title MECOSAN
Author/s Gabriele Palozzi, Antonio Chirico, Leonardo Calò
Publishing Year 2014 Issue 2014/90 Language Italian
Pages 28 P. 71-98 File size 477 KB
DOI is like a bar code for intellectual property: to have more infomation click here
Below, you can see the article first page
If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits
FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.
The study aimed at assessing current direct costs of 1-year implantable cardioverter defibrillator (ICD) follow-up based on Remote Monitoring system compared with conventional quarterly in-hospital traditional follow-ups, considering all direct costs burdened on patients and hospital. Patients (N = 233) with indications for ICD were consecutively recruited in two homogeneous population and randomized at implant to be followed-up for 12 ± 3 months. Direct Costs were calculated distinguishing between provider and patient costs, through an ABC estimation made by empirical observation and direct surveys. Moving from the traditional cost accounting rules, it was estimate that direct costs were significantly reduced in the RM group; any patient could save about € 156/year while the hospital could save about € 20 per patient/year.
Keywords: Cost-analysis, telemedicine, remote monitoring (RM), implantable cardioverter defibrillator (ICD), health technology assessment, health care management.
Gabriele Palozzi, Antonio Chirico, Leonardo Calò, Cost accounting del follow-up annuo per il controllo remoto dei defibrillatori impiantabili in "MECOSAN" 90/2014, pp 71-98, DOI: 10.3280/MESA2014-090005